Endometrial cancer: hormonal factors, the perimenopausal "window of risk," and isoflavones.
Hale
G E
GE
Center for Women's Health, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.
Hughes
C L
CL
Cline
J M
JM
D000367:Age Factors; D002979:Climacteric; D048909:Diabetes Complications; D004032:Diet; D004714:Endometrial Hyperplasia / Q000517:prevention & control; D016889:Endometrial Neoplasms / Q000209:etiology* / Q000378:metabolism; D004967:Estrogens / Q000097:blood / Q000378:metabolism* / Q000652:urine; D015444:Exercise; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D007529:Isoflavones / Q000378:metabolism / Q000627:therapeutic use; D008137:Longitudinal Studies; D009765:Obesity / Q000150:complications; D011374:Progesterone / Q000378:metabolism* / Q000627:therapeutic use; D012307:Risk Factors
D004967:Estrogens; D007529:Isoflavones; D011374:Progesterone